Curio Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-16
Closed -$970 – 217
2026
Q1
$970 Buy
16
+4
+33% +$233 ﹤0.01% 382
2025
Q4
$659 Buy
+12
New +$577 ﹤0.01% 391
2025
Q3
– Sell
-92
Closed -$4.25K – 290
2025
Q2
$4.25K Buy
92
+90
+4,500% +$4.42K ﹤0.01% 246
2025
Q1
$5.17K Sell
2
-78
-98% -$4.55K ﹤0.01% 264
2024
Q4
$4.53K Buy
+80
New +$4.47K ﹤0.01% 244

Other funds holding BMY

Curio Wealth's BMY Position: Q2 2026 in Review

Curio Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 16 shares — an estimated $970 sold.

Curio Wealth first reported a position in BMY in Q4 2024 and held it in 5 quarters. The position peaked at $5.17K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Curio Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Curio Wealth sold 16 Bristol-Myers Squibb shares in Q2 2026, an estimated $970.
  • Curio Wealth first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 5 quarters.
  • Curio Wealth's Bristol-Myers Squibb position peaked at $5.17K in Q1 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.